Table of Content

1. Preface
? ? 1.1. Market Definition and Scope
? ? 1.2. Market Segmentation
? ? 1.3. Key Research Objectives
? ? 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global mRNA Vaccine Market

4. Market Overview
? ? 4.1. Introduction
? ? 4.2. Overview
? ? 4.3. Market Dynamics
? ? ? ? 4.3.1. Drivers
? ? ? ? 4.3.2. Restraints
? ? ? ? 4.3.3. Opportunities
? ? 4.4. Global mRNA Vaccine Market Analysis and Forecasts, 2020-2034
? ? 4.5. Porter’s Five Force Analysis

5. Key Insights
? ? 5.1. Technological Advancements
? ? 5.2. mRNA Vaccines Pipeline
? ? 5.3. Regulatory Scenario by Region/Globally
? ? 5.4. COVID-19 Pandemic Impact Analysis on Industry

6. Global mRNA Vaccine Market Analysis and Forecasts, By Application
? ? 6.1. Introduction & Definition
? ? 6.2. Key Findings / Developments
? ? 6.3. Market Value Forecast By Application, 2020-2034
? ? ? ? 6.3.1. COVID-19
? ? ? ? 6.3.2. Others
? ? 6.4. Market Attractiveness By Application

7. Global mRNA Vaccine Market Analysis and Forecasts, By End-user
? ? 7.1. Introduction & Definition
? ? 7.2. Key Findings / Developments
? ? 7.3. Market Value Forecast By End-user, 2020-2034
? ? ? ? 7.3.1. Government Entities
? ? ? ? 7.3.2. Private Hospitals & Clinics
? ? ? ? 7.3.3. Others
? ? 7.4. Market Attractiveness By End-user

8. Global mRNA Vaccine Market Analysis and Forecasts, By Region
? ? 8.1. Key Findings
? ? 8.2. Market Value Forecast By Region
? ? ? ? 8.2.1. North America
? ? ? ? 8.2.2. Europe
? ? ? ? 8.2.3. Asia Pacific
? ? ? ? 8.2.4. Latin America
? ? ? ? 8.2.5. Middle East & Africa
? ? 8.3. Market Attractiveness By Country/Region

9. North America mRNA Vaccine Market Analysis and Forecast
? ? 9.1. Introduction
? ? ? ? 9.1.1. Key Findings
? ? 9.2. Market Value Forecast By Application, 2020-2034
? ? ? ? 9.2.1. COVID-19
? ? ? ? 9.2.2. Others
? ? 9.3. Market Value Forecast By End-user, 2020-2034
? ? ? ? 9.3.1. Government Entities
? ? ? ? 9.3.2. Private Hospitals & Clinics
? ? ? ? 9.3.3. Others
? ? 9.4. Market Value Forecast By Country, 2020-2034
? ? ? ? 9.4.1. U.S.
? ? ? ? 9.4.2. Canada
? ? 9.5. Market Attractiveness Analysis
? ? ? ? 9.5.1. By Application
? ? ? ? 9.5.2. By End-user
? ? ? ? 9.5.3. By Country

10. Europe mRNA Vaccine Market Analysis and Forecast
? ? 10.1. Introduction
? ? ? ? 10.1.1. Key Findings
? ? 10.2. Market Value Forecast By Application, 2020-2034
? ? ? ? 10.2.1. COVID-19
? ? ? ? 10.2.2. Others
? ? 10.3. Market Value Forecast By End-user, 2020-2034
? ? ? ? 10.3.1. Government Entities
? ? ? ? 10.3.2. Private Hospitals & Clinics
? ? ? ? 10.3.3. Others
? ? 10.4. Market Value Forecast By Country, 2020-2034
? ? ? ? 10.4.1. Germany
? ? ? ? 10.4.2. U.K.
? ? ? ? 10.4.3. France
? ? ? ? 10.4.4. Spain
? ? ? ? 10.4.5. Italy
? ? ? ? 10.4.6. Rest of Europe
? ? 10.5. Market Attractiveness Analysis
? ? ? ? 10.5.1. By Application
? ? ? ? 10.5.2. By End-user
? ? ? ? 10.5.3. By Country

11. Asia Pacific mRNA Vaccine Market Analysis and Forecast
? ? 11.1. Introduction
? ? ? ? 11.1.1. Key Findings
? ? 11.2. Market Value Forecast By Application, 2020-2034
? ? ? ? 11.2.1. COVID-19
? ? ? ? 11.2.2. Others
? ? 11.3. Market Value Forecast By End-user, 2020-2034
? ? ? ? 11.3.1. Government Entities
? ? ? ? 11.3.2. Private Hospitals & Clinics
? ? ? ? 11.3.3. Others
? ? 11.4. Market Value Forecast By Country, 2020-2034
? ? ? ? 11.4.1. China
? ? ? ? 11.4.2. Japan
? ? ? ? 11.4.3. India
? ? ? ? 11.4.4. Australia & New Zealand
? ? ? ? 11.4.5. Rest of Asia Pacific
? ? 11.5. Market Attractiveness Analysis
? ? ? ? 11.5.1. By Application
? ? ? ? 11.5.2. By End-user
? ? ? ? 11.5.3. By Country

12. Latin America mRNA Vaccine Market Analysis and Forecast
? ? 12.1. Introduction
? ? ? ? 12.1.1. Key Findings
? ? 12.2. Market Value Forecast By Application, 2020-2034
? ? ? ? 12.2.1. COVID-19
? ? ? ? 12.2.2. Others
? ? 12.3. Market Value Forecast By End-user, 2020-2034
? ? ? ? 12.3.1. Government Entities
? ? ? ? 12.3.2. Private Hospitals & Clinics
? ? ? ? 12.3.3. Others
? ? 12.4. Market Value Forecast By Country, 2020-2034
? ? ? ? 12.4.1. Brazil
? ? ? ? 12.4.2. Mexico
? ? ? ? 12.4.3. Rest of Latin America
? ? 12.5. Market Attractiveness Analysis
? ? ? ? 12.5.1. By Application
? ? ? ? 12.5.2. By End-user
? ? ? ? 12.5.3. By Country

13. Middle East & Africa mRNA Vaccine Market Analysis and Forecast
? ? 13.1. Introduction
? ? ? ? 13.1.1. Key Findings
? ? 13.2. Market Value Forecast By Application, 2020-2034
? ? ? ? 13.2.1. COVID-19
? ? ? ? 13.2.2. Others
? ? 13.3. Market Value Forecast By End-user, 2020-2034
? ? ? ? 13.3.1. Government Entities
? ? ? ? 13.3.2. Private Hospitals & Clinics
? ? ? ? 13.3.3. Others
? ? 13.4. Market Value Forecast By Country, 2020-2034
? ? ? ? 13.4.1. GCC Countries
? ? ? ? 13.4.2. South Africa
? ? ? ? 13.4.3. Rest of Middle East & Africa
? ? 13.5. Market Attractiveness Analysis
? ? ? ? 13.5.1. By Application
? ? ? ? 13.5.2. By End-user
? ? ? ? 13.5.3. By Country

14. Competition Landscape
? ? 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
? ? 14.2. Market Share Analysis By Company (2022)
? ? 14.3. Company Profiles
? ? ? ? 14.3.1. Pfizer, Inc.
? ? ? ? ? ? 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
? ? ? ? ? ? 14.3.1.2. Product Portfolio
? ? ? ? ? ? 14.3.1.3. Financial Overview
? ? ? ? ? ? 14.3.1.4. SWOT Analysis
? ? ? ? ? ? 14.3.1.5. Strategic Overview
? ? ? ? 14.3.2. Moderna Inc.
? ? ? ? ? ? 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
? ? ? ? ? ? 14.3.2.2. Product Portfolio
? ? ? ? ? ? 14.3.2.3. Financial Overview
? ? ? ? ? ? 14.3.2.4. SWOT Analysis
? ? ? ? ? ? 14.3.2.5. Strategic Overview
? ? ? ? 14.3.3. Novartis AG
? ? ? ? ? ? 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
? ? ? ? ? ? 14.3.3.2. Product Portfolio
? ? ? ? ? ? 14.3.3.3. Financial Overview
? ? ? ? ? ? 14.3.3.4. SWOT Analysis
? ? ? ? ? ? 14.3.3.5. Strategic Overview
? ? ? ? 14.3.4. Sanofi
? ? ? ? ? ? 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
? ? ? ? ? ? 14.3.4.2. Product Portfolio
? ? ? ? ? ? 14.3.4.3. Financial Overview
? ? ? ? ? ? 14.3.4.4. SWOT Analysis
? ? ? ? ? ? 14.3.4.5. Strategic Overview
? ? ? ? 14.3.5. Arcturus Therapeutics
? ? ? ? ? ? 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
? ? ? ? ? ? 14.3.5.2. Product Portfolio
? ? ? ? ? ? 14.3.5.3. Financial Overview
? ? ? ? ? ? 14.3.5.4. SWOT Analysis
? ? ? ? ? ? 14.3.5.5. Strategic Overview
? ? ? ? 14.3.6. Gennova Biopharmaceuticals Ltd
? ? ? ? ? ? 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
? ? ? ? ? ? 14.3.6.2. Product Portfolio
? ? ? ? ? ? 14.3.6.3. Financial Overview
? ? ? ? ? ? 14.3.6.4. SWOT Analysis
? ? ? ? ? ? 14.3.6.5. Strategic Overview
? ? ? ? 14.3.7. Aimei Vaccine Co., Ltd
? ? ? ? ? ? 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
? ? ? ? ? ? 14.3.7.2. Product Portfolio
? ? ? ? ? ? 14.3.7.3. Financial Overview
? ? ? ? ? ? 14.3.7.4. SWOT Analysis
? ? ? ? ? ? 14.3.7.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global mRNA Vaccine Market Value (US$ Mn) Forecast, 2020-2034

Figure 02: Global mRNA Vaccine Market Value Share, By Application, 2023

Figure 03: Global mRNA Vaccine Market Value Share, by End-User, 2023

Figure 04: Global mRNA Vaccine Market Value Share, by Region, 2023

Figure 05: Global mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 06: Global mRNA Vaccine Market Share Analysis, by Application, 2023

Figure 07: Global mRNA Vaccine Market Share Analysis, by Application, 2034

Figure 08: Global mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034

Figure 09: Global mRNA Vaccine Market Value (US$ Mn), by COVID-19, 2020-2034

Figure 10: Global mRNA Vaccine Market Value Share Analysis, by COVID-19, 2023 and 2034

Figure 11: Global mRNA Vaccine Market Value (US$ Mn), by Others, 2020-2034

Figure 12: Global mRNA Vaccine Market Value Share Analysis, by Others, 2023 and 2034

Figure 13: Global mRNA Vaccine Market Value (US$ Mn) Share Analysis, by End-User, 2023 and 2034

Figure 14: Global mRNA Vaccine Market Share Analysis, by End-User, 2023

Figure 15: Global mRNA Vaccine Market Share Analysis, by End-User, 2034

Figure 16: Global mRNA Vaccine Market Attractiveness Analysis, by End-User, 2024-2034

Figure 17: Global mRNA Vaccine Market Value (US$ Mn), by Government Entities, 2020-2034

Figure 18: Global mRNA Vaccine Market Value Share Analysis, by Government Entities, 2023 and 2034

Figure 19: Global mRNA Vaccine Market Value (US$ Mn), by Private Hospitals & Clinics, 2020-2034

Figure 20: Global mRNA Vaccine Market Value Share Analysis, by Private Hospitals & Clinics, 2023 and 2034

Figure 21: Global mRNA Vaccine Market Value (US$ Mn), by Others, 2020-2034

Figure 22: Global mRNA Vaccine Market Value Share Analysis, by Other, 2023 and 2034

Figure 23: Global mRNA Vaccine Market Value Share Analysis, by Region, 2023 and 2034

Figure 24: Global mRNA Vaccine Market Share Analysis, by Region, 2023

Figure 25: Global mRNA Vaccine Market Share Analysis, by Region, 2034

Figure 26: Global mRNA Vaccine Market Attractiveness Analysis, by Region, 2024-2034

Figure 27: North America mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 28: North America mRNA Vaccine Market Value Share Analysis, by Country, 2023 and 2034

Figure 29: North America mRNA Vaccine Market Attractiveness Analysis, by Country, 2024-2034

Figure 30: North America mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 31: North America mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034

Figure 32: North America mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034

Figure 33: North America mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034

Figure 34: Europe mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 35: Europe mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 36: Europe mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 37: Europe mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 38: Europe mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034

Figure 39: Europe mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034

Figure 40: Europe mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034

Figure 41: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 42: Asia Pacific mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 43: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 44: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 45: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034

Figure 46: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034

Figure 47: Asia Pacific mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034

Figure 48: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 49: Latin America mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 50: Latin America mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 51: Latin America mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 52: Latin America mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034

Figure 53: Latin America mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034

Figure 54: Latin America mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034

Figure 55: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 56: Middle East & Africa mRNA Vaccine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 58: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034

Figure 59: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, by Application, 2024-2034

Figure 60: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Share Analysis, By End-User, 2023 and 2034

Figure 61: Middle East & Africa mRNA Vaccine Market Attractiveness Analysis, By End-User, 2024-2034

List of Tables

List of Tables

Table 01: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034

Table 02: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034

Table 03: Global mRNA Vaccine Market Value (US$ Mn) Forecast, by Region, 2020-2034

Table 04: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by Country, 2020-2034

Table 05: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034

Table 06: North America mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034

Table 07: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 08: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034

Table 09: Europe mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034

Table 10: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 11: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034

Table 12: Asia Pacific mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034

Table 13: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034

Table 15: Latin America mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034

Table 16: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 17: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by Application, 2020-2034

Table 18: Middle East & Africa mRNA Vaccine Market Value (US$ Mn) Forecast, by End-User, 2020-2034